Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-07
2006-02-07
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S131000, C548S143000, C548S215000, C548S250000, C548S262200, C548S311100, C548S314700, C548S364100, C548S542000, C514S374000, C514S381000, C514S424000
Reexamination Certificate
active
06995182
ABSTRACT:
The present invention is a series of compounds that are derivatives of 1-sulfonyl-pyrrolidine and that demonstrate affinity towards metabotropic glutamate receptors. The invention further relates to medicaments containing these compounds and to a process for their preparation. The compounds possess affinity towards metabotropic glutamate receptors and are therefore useful in the treatment or prevention of acute and/or chronic neurological disorders.
REFERENCES:
patent: 3905979 (1975-09-01), Henry et al.
patent: 4539411 (1985-09-01), Broger et al.
patent: 5036153 (1991-07-01), Braish et al.
patent: 6143776 (2000-11-01), Erlanson
patent: 6284785 (2001-09-01), Mutel et al.
patent: 6469036 (2002-10-01), Costanzo et al.
patent: 6645939 (2003-11-01), Durette et al.
patent: 6649763 (2003-11-01), Yoon et al.
patent: WO 97/48681 (1997-12-01), None
patent: WO 98/35675 (1998-08-01), None
patent: WO 99/26615 (1999-06-01), None
patent: WO 99/45006 (1999-09-01), None
patent: WO 99/62888 (1999-12-01), None
patent: WO 00/37458 (2000-06-01), None
patent: WO 00/58285 (2000-10-01), None
Holladay et al (1999): STN International CAPLUS database, Columbus (Ohio), Accession No., 1999: 421682.
P. Bravo et al.,Tetrahedron Letters, vol. 40, pp. 6317-6320 (1999).
Pascal Coric et al.,J. Med. Chem., vol. 39, pp. 2594-2608 (1996).
Carmen Najera etal.,Tetrahedron Asymmetry, vol. 10, pp. 2245-2303 (1999).
E. J. Schlager and K.Christensen,Cytotechnology, vol. 30, pp. 71-83 (1999).
Wouter et al.,Synlett, pp. 1079-1080 (Sep. 1997).
B. J. Littler et al.,Synlett, vol. 1, pp. 22-24 (1997).
Katzsukiyo et al.,Organic Letters, vol. 2, No. 3, pp. 385-388 (2000).
Mutel Vincent
Wichmann Juergen
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
Shameem Golam M. M.
LandOfFree
1-sulfonyl pyrrolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-sulfonyl pyrrolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-sulfonyl pyrrolidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687098